Bevaris

Bevaris 100 mg (Bevacizumab): Complete Guide to Uses, Dosage, Benefits, Side Effects & FAQS

Bevaris 100 mg is a highly potent prescription medication categorized under Oncology & Cancer Medicines, Anticancer Medicines, and Biologics & Biosimilars. This guide provides a detailed overview of Bevaris 100 mg, featuring the active generic ingredient Bevacizumab, to explain its role in targeted cancer therapy and managing advanced inflammatory vascular conditions.

---

H3: Bevaris 100 mg (Bevacizumab): Complete Guide to Targeted Cancer Therapy

Bevaris 100 mg is an advanced biological therapy used primarily in the treatment of various types of cancers. It belongs to a specialized group of medicines known as monoclonal antibodies. Unlike traditional chemotherapy that attacks all rapidly dividing cells, Bevaris 100 mg acts as a precision controller, targeting specific proteins that tumors need to grow and spread. This targeted approach represents a shift toward more manageable and effective long-term disease management.

H4: Drug Class and Mechanism of Action

Bevaris 100 mg is classified as an angiogenesis inhibitor and a monoclonal antibody. The active ingredient, Bevacizumab, works by interrupting specific signaling pathways involving Vascular Endothelial Growth Factor (VEGF). VEGF is a protein that stimulates the growth of new blood vessels. In cancerous conditions, these signals become overactive, allowing tumors to create their own blood supply. Bevacizumab works by blocking VEGF, reducing inflammatory signaling at its source, and effectively “starving” the tumor of the nutrients it needs to survive.

H4: Medical Uses of Bevaris 100 mg

Bevaris 100 mg is approved for several conditions where abnormal blood vessel growth and excessive immune signaling are present:

• Metastatic Colorectal Cancer: Often used in combination with chemotherapy to slow disease progression.

• Non-Small Cell Lung Cancer: Targeted therapy for advanced or recurrent lung conditions.

• Glioblastoma: Used for adults with specific types of brain tumors when other treatments have not worked.

• Renal Cell Carcinoma: Prescribed for advanced kidney cancer.

• Symptom Relief: Benefits include reduced tumor-related swelling and relieved pain associated with tissue pressure.

H4: Who Can Take Bevaris 100 mg?

Proper medical evaluation is essential before starting treatment with Bevacizumab.

• Eligibility: You may be considered for Bevaris 100 mg if you have a diagnosed malignancy that expresses specific vascular growth patterns.

• Who Should Avoid: Individuals with severe high blood pressure, a history of blood clots, or those with recent surgical wounds that haven’t healed should avoid Bevaris 100 mg.

• Pregnancy: It should be avoided by those who are pregnant or breastfeeding as Bevacizumab can cause harm to the developing fetus.

H4: Dosage and Administration

The administration of Bevaris 100 mg follows strict clinical protocols:

• Standard Dosage: The dose of Bevaris 100 mg is calculated based on body weight and the specific condition being treated.

• Administration: This is an Injectable Medicine administered as an intravenous (IV) infusion by a healthcare professional in a clinical setting.

• Schedule: Infusions are typically given every 2 or 3 weeks.

• Monitoring: Regular blood pressure checks and urine tests are required throughout the treatment with Bevacizumab.

H4: Benefits of Bevaris 100 mg

Key advantages of Bevaris 100 mg include:

• Targeted Modulation: Offers precise control over the growth of tumor-feeding blood vessels.

• Combination Synergy: Works effectively alongside other therapies to enhance overall treatment outcomes.

• Slowing Progression: Significant clinical evidence supports the effectiveness of Bevacizumab in extending progression-free survival.

• Safety Profile: Features a well-studied profile for long-term use under professional medical supervision.

H4: Side Effects of Bevaris 100 mg

While Bevaris 100 mg is a breakthrough therapy, some side effects may occur:

• Common Side Effects: High blood pressure, headache, nosebleeds, and back pain.

• Serious Side Effects: Rare instances of gastrointestinal perforation, blood clots, or impaired wound healing.

• Immediate Attention: Seek medical attention immediately if you notice shortness of breath, sudden chest pain, or severe abdominal pain.

H4: Frequently Asked Questions (FAQs)

1. Is Bevaris 100 mg a chemotherapy drug? No, Bevaris 100 mg is a targeted biological therapy (Bevacizumab), though it is often used alongside chemotherapy.

2. Can it be taken with food? As an IV infusion, its absorption is not affected by food, but maintaining good nutrition during treatment is vital.

3. Is Bevaris 100 mg a steroid? No, Bevacizumab is a monoclonal antibody, not a corticosteroid.

H4: Conclusion

Bevaris 100 mg (Bevacizumab) is a targeted therapy designed to control overactive vascular growth and inflammatory signaling in oncology. By addressing the tumor’s blood supply at its source, it helps reduce disease impact and improve daily function. When used responsibly under professional guidance, Bevacizumab is a valuable option for modern cancer management